BRIDGEBIO PHARMA INC

CUSIP: 10806XAD4 Class: Convertible Debt

Russell Investments Group, Ltd.'s Holding History (CIK: 0001692234)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025
Shares 1,657,000 Value ($000) $1,644 Avg Close — Range —
Q2 2025
Shares 3,228,000 Value ($000) $3,058 Avg Close — Range —
Q1 2025
Shares 3,472,000 Value ($000) $3,132 Avg Close — Range —
Q4 2024
Shares 1,702,000 Value ($000) $1,474 Avg Close — Range —
Q3 2024
Shares 1,118,000 Value ($000) $939 Avg Close — Range —
Q2 2024
Shares 513,000 Value ($000) $419 Avg Close — Range —
Q1 2024
Shares 991,000 Value ($000) $818 Avg Close — Range —
Q4 2023
Shares 1,173,000 Value ($000) $1,007 Avg Close — Range —
Q3 2023
Shares 1,515,000 Value ($000) $1,158 Avg Close — Range —
Q2 2023
Shares 1,713,000 Value ($000) $1,069 Avg Close — Range —
Q1 2023
Shares 1,016,000 Value ($000) $653 Avg Close — Range —